Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy: A Meta-Analysis of DAPA-HF and DELIVER

被引：0
|
作者：
Butt, Jawad H. [1 ,2 ,3 ]
Shen, Li [1 ]
Inzucchi, Silvio E. [4 ]
Docherty, Kieran F. [1 ]
Jhund, Pardeep S. [1 ]
Martinez, Felipe A. [5 ]
Sabatine, Marc S. [6 ]
Vaduganathan, Muthiah [6 ]
Solomon, Scott D. [6 ]
McMurray, John J. V. [1 ]
机构：
[1] Univ Glasgow, Glasgow, Scotland
[2] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[3] Zealand Univ Hosp, Roskilde, Denmark
[4] Yale Sch Med, New Haven, CT USA
[5] Univ Cordoba, Cordoba, Argentina
[6] Brigham & Womens Hosp, Boston, MA USA
来源：
JACC-HEART FAILURE | 2024年 / 12卷 / 11期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.jchf.2024.07.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1946 / 1948
页数：3
相关论文
共 50 条
  • [21] Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
    Rossing, Peter
    Inzucchi, Silvio E.
    Vart, Priya
    Jongs, Niels
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    DeMets, David L.
    Bengtsson, Olof
    Lindberg, Magnus
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Stefansson, Bergur, V
    Karlsson, Cecilia
    Chertow, Glenn M.
    Hou, Fan Fan
    Correa-Rotter, Ricardo
    Toto, Robert D.
    Wheeler, David C.
    McMurray, John J., V
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (01): : 24 - 34
  • [22] The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
    McMurray, John J. V.
    Solomon, Scott D.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    EUROPEAN HEART JOURNAL, 2021, 42 (13) : 1199 - 1202
  • [23] Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF
    Docherty, Kieran F.
    Welsh, Paul
    Verma, Subodh
    De Boer, Rudolf A.
    O'Meara, Eileen
    Bengtsson, Olof
    Kober, Lars
    Kosiborod, Mikhail N.
    Hammarstedt, Ann
    Langkilde, Anna Maria
    Lindholm, Daniel
    Little, Dustin J.
    Sjostrand, Mikaela
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Morrow, David A.
    Schou, Morten
    Solomon, Scott D.
    Sattar, Naveed
    Jhund, Pardeep S.
    McMurray, John J., V
    CIRCULATION, 2022, 146 (13) : 980 - 994
  • [24] The Effect of Dapagliflozin on Anemia in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF
    Docherty, Kieran
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    Martinez, Feilpe
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjastrand, Mikaela
    Solomon, Scott
    Jhund, Pardeep S.
    McMurray, John J.
    CIRCULATION, 2020, 142
  • [25] Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER data
    Davis, Jason A.
    Booth, David
    Mcewan, Phil
    Solomon, Scott D.
    Mcmurray, John J. V.
    de Boer, Rudolf A.
    Comin-Colet, Josep
    Bachus, Erasmus
    Chen, Jieling
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (03) : 664 - 673
  • [26] Good for your heart and safe for your toes: a patient-level meta-analysis of DAPA-HF and DELIVER
    Arnott, Clare
    Neal, Bruce
    EUROPEAN HEART JOURNAL, 2023, 44 (24) : 2184 - 2186
  • [27] A pooled health-economic analysis of DAPA-HF and DELIVER: A French cost-effectiveness analysis of dapagliflozin for the treatment of patients with heart failure
    Chen, J. Jieling
    Booth, D.
    Davis, J. A.
    Mcewan, P.
    De Boer, R. A.
    Comin-Colet, J.
    Solomon, S. D.
    Bachus, E.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 159 - 159
  • [28] Effects of dapagliflozin according to QRS duration across the spectrum of LVEF: An analysis of DAPA-HF and DELIVER
    Abdin, A.
    Kondo, T.
    Boehm, M.
    Jhund, P. S.
    Vaduganathan, M.
    Lam, C. S. P.
    De Boer, R.
    Kosiborod, M. N.
    Desai, A. S.
    Kober, L.
    Ponikowski, P.
    Martinez, F. A.
    Hernandez, A.
    Solomon, S.
    Mcmurray, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [29] Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
    Jackson, Alice M.
    Dewan, Pooja
    Anand, Inder S.
    Belohlavek, Jan
    Bengtsson, Olof
    de Boer, Rudolf A.
    Boehm, Michael
    Boulton, David W.
    Chopra, Vijay K.
    DeMets, David L.
    Docherty, Kieran F.
    Dukat, Andrej
    Greasley, Peter J.
    Howlett, Jonathan G.
    Inzucchi, Silvio E.
    Katova, Tzvetana
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Ljungman, Charlotta E. A.
    Martinez, Felipe A.
    O'Meara, Eileen
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Tereshchenko, Sergey
    Verma, Subodh
    Jhund, Pardeep S.
    McMurray, John J. V.
    CIRCULATION, 2020, 142 (11) : 1040 - 1054
  • [30] Defining Severe Heart Failure across the Ejection Fraction Spectrum in DAPA-HF and DELIVER
    Inciardi, Riccardo
    Lu, Henri
    Claggett, Brian
    Desai, Akshay
    Jhund, Pardeep
    Lam, Carolyn
    Kosiborod, Mikhail
    Inzucchi, Silvio
    Martinez, Felipe
    De Boer, Rudolf
    Hernandez, Adrian
    Shah, Sanjiv
    Kober, Lars
    Ponikowski, Piotr
    Sabatine, Marc
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John
    Vaduganathan, Muthiah
    Solomon, Scott
    CIRCULATION, 2024, 150
12345